抗VEGF抗體的組合物和方法

• 收藏
• 分享

专利权人:

Peregrine Pharmaceuticals Inc.

发明人:

KAVLIE, Anita,SCHLUNEGGER, Kyle

申请号：

HK11101691.7

公开号：

HK1147445B

申请日:

2011.02.21

申请国别(地区):

HK

年份:

2016

代理人:

摘要：

Disclosed are human antibodies that specifically inhibit VEGF binding to only one (VEGFR2) of the two primary VEGF receptors. The antibodies effectively inhibit angiogenesis and induce tumor regression, and yet have improved safety due to their specificity. The present invention thus provides new human antibody-based compositions, methods and combined protocols for treating cancer and other angiogenic diseases. Advantageous immunoconjugate compositions and methods using the new VEGF-specific human antibodies are also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/